These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20619170)

  • 41. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American Society for Transplantation and Cellular Therapy International Affairs Committee: Report of the 4th Workshop on Quality as a Development Tool for Hematopoietic Cell Transplantation Programs at the 2023 Tandem BMT Meetings.
    Ramirez P; Atsuta Y; Alseraihy A; Okamoto S; Teshima T; Aljurf M; Majhail NS; Rondelli D; Chao N; Flowers ME
    Transplant Cell Ther; 2024 May; 30(5):468-474. PubMed ID: 38346644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
    Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H
    Bone Marrow Transplant; 2020 Apr; 55(4):838-839. PubMed ID: 31754251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time process/quality control for HPC processing.
    Arpagaus M; Leibundgut EO; Zbären K; Brunold C; Ischi E; Tobler A; Zwicky C
    Cytotherapy; 2004; 6(5):505-13. PubMed ID: 15512917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Just another cost increasing exercise (JACIE)?
    Apperley J
    Bone Marrow Transplant; 2004 Nov; 34(10):835-8. PubMed ID: 15517004
    [No Abstract]   [Full Text] [Related]  

  • 46. Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey.
    Gratwohl A; Baldomero H; Labar B; Apperley J; Urbano-Ispizua A;
    Croat Med J; 2004 Dec; 45(6):689-94. PubMed ID: 15578801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.
    Reiffers J; Goldman J; Meloni G; Cahn JY; Gratwohl A
    Bone Marrow Transplant; 1994 Sep; 14(3):407-10. PubMed ID: 7994263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry.
    Fouillard L; Labopin M; Gratwohl A; Powles R; Bacigalupo A; Bego G; Chesnel V; Gorin NC;
    Bone Marrow Transplant; 2002 Nov; 30(10):637-43. PubMed ID: 12420201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation.
    Holbro A; Baldomero H; Lanza F; Chabannon C; Snowden JA; Buser A; Infanti L; Worel N; Sureda A; Badoglio M; Passweg J; Bonini C;
    Cytotherapy; 2018 Mar; 20(3):453-460. PubMed ID: 29352666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.
    Neymark N; Rosti G
    Haematologica; 2000 Jul; 85(7):733-44. PubMed ID: 10897126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
    Shimoni A; Smith TL; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno NT; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 Apr; 27(8):821-8. PubMed ID: 11477439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy.
    Lombardini L; Bosi A; Grosz S; Pamphilon D; Fehily D; Mareri M; Carella C; Pia Mariani M; Pupella S; Grazzini G; Costa AN
    Vox Sang; 2013 Aug; 105(2):174-6. PubMed ID: 23398286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
    Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA
    Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
    Bengala C; Guarneri V; Ledermann J; Rosti G; Wandt H; Lotz JP; Cure JH; Orlandini C; Ferrante P; Conte PF; Demirer T;
    Bone Marrow Transplant; 2005 Jul; 36(1):25-31. PubMed ID: 15908977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous stem-cell transplantation in multiple myeloma.
    Gahrton G
    Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
    Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
    Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
    Fassas A; Kimiskidis VK
    J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. JACIE accreditation in 2008: demonstrating excellence in stem cell transplantation.
    Pamphilon D; Apperley JF; Samson D; Slaper-Cortenbach I; McGrath E
    Hematol Oncol Stem Cell Ther; 2009; 2(2):311-9. PubMed ID: 20118054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
    Schmitz N; Gratwohl A; Goldman JM
    Bone Marrow Transplant; 1996 Apr; 17(4):471-7. PubMed ID: 8722341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.